Xu-Jian Luo

473 total citations
22 papers, 429 citations indexed

About

Xu-Jian Luo is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Xu-Jian Luo has authored 22 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Xu-Jian Luo's work include Metal complexes synthesis and properties (14 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and DNA and Nucleic Acid Chemistry (7 papers). Xu-Jian Luo is often cited by papers focused on Metal complexes synthesis and properties (14 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and DNA and Nucleic Acid Chemistry (7 papers). Xu-Jian Luo collaborates with scholars based in China and Canada. Xu-Jian Luo's co-authors include Yan‐Cheng Liu, Qi‐Pin Qin, Hong Liang, Zhen‐Feng Chen, Ting Meng, Ming‐Xiong Tan, Yulan Li, Guohai Zhang, Ke-Bin Huang and Bi‐Qun Zou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Xu-Jian Luo

22 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu-Jian Luo China 11 211 196 167 61 55 22 429
Zu‐Zhuang Wei China 13 252 1.2× 194 1.0× 209 1.3× 72 1.2× 55 1.0× 23 503
Dragana Mitić Serbia 14 286 1.4× 273 1.4× 85 0.5× 138 2.3× 76 1.4× 34 534
Jiao-Lan Qin China 12 418 2.0× 362 1.8× 257 1.5× 100 1.6× 80 1.5× 17 703
Ladislav Habala Slovakia 12 193 0.9× 165 0.8× 90 0.5× 57 0.9× 43 0.8× 29 394
Narayanaperumal Pravin India 13 280 1.3× 268 1.4× 106 0.6× 82 1.3× 64 1.2× 23 447
Waddhaah M. Al–Asbahy Yemen 7 301 1.4× 175 0.9× 303 1.8× 39 0.6× 88 1.6× 16 465
Sourav De India 12 181 0.9× 334 1.7× 120 0.7× 35 0.6× 53 1.0× 37 508
M. Serdar Çavuş Türkiye 14 114 0.5× 398 2.0× 107 0.6× 20 0.3× 54 1.0× 34 513
Tomasz Kosmalski Poland 9 137 0.6× 177 0.9× 71 0.4× 55 0.9× 55 1.0× 21 346
Gabrieli L. Parrilha Brazil 13 353 1.7× 351 1.8× 85 0.5× 180 3.0× 96 1.7× 19 573

Countries citing papers authored by Xu-Jian Luo

Since Specialization
Citations

This map shows the geographic impact of Xu-Jian Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu-Jian Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu-Jian Luo more than expected).

Fields of papers citing papers by Xu-Jian Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu-Jian Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu-Jian Luo. The network helps show where Xu-Jian Luo may publish in the future.

Co-authorship network of co-authors of Xu-Jian Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xu-Jian Luo. A scholar is included among the top collaborators of Xu-Jian Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu-Jian Luo. Xu-Jian Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shouchuan, et al.. (2024). Discovery, synthesis, and anti-cancer evaluation of 10-Pterostilbene methylamine hydrochloride derivatives as potential COX-2 and Topo I dual inhibitors. Journal of Molecular Structure. 1311. 138363–138363. 3 indexed citations
3.
Yang, Yan, et al.. (2019). Novel Quinoline-based Ir(III) Complexes Exhibit High Antitumor Activity in Vitro and in Vivo. ACS Medicinal Chemistry Letters. 10(12). 1614–1619. 15 indexed citations
4.
Qin, Qi‐Pin, Ting Meng, Ming‐Xiong Tan, et al.. (2017). Synthesis, crystal structure and biological evaluation of a new dasatinib copper(II) complex as telomerase inhibitor. European Journal of Medicinal Chemistry. 143. 1597–1603. 49 indexed citations
5.
Qin, Qi‐Pin, Ting Meng, Ming‐Xiong Tan, et al.. (2017). Synthesis and in vitro biological evaluation of three 4′-(4-methoxyphenyl)-2,2′:6′,2″-terpyridine iridium(III) complexes as new telomerase inhibitors. European Journal of Medicinal Chemistry. 143. 1387–1395. 30 indexed citations
6.
Yang, Yan, Changgui Li, Xu-Jian Luo, et al.. (2016). The Lone-Pair Stereochemistry and Its Effect on Supramolecular Interaction of Dinuclear Pb(II) Dicarboxylate Compound With 2,6-Bis(benzimidazolyl)pyridine. Synthesis and Reactivity in Inorganic Metal-Organic and Nano-Metal Chemistry. 46(9). 1376–1380. 4 indexed citations
7.
Chen, Zhen‐Feng, Qi‐Pin Qin, Jiao-Lan Qin, et al.. (2015). Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Tumor Cell Apoptosis by Organoplatinum(II) Complexes with Oxoisoaporphine. Journal of Medicinal Chemistry. 58(5). 2159–2179. 158 indexed citations
9.
Yang, Yan, et al.. (2015). Synthesis and DNA interaction of the novel mixed-ligand polymers that incorporate bis(2-benzimidazolylmethyl) sulfide. Supramolecular chemistry. 28(3-4). 321–328. 1 indexed citations
10.
Yang, Yan, Changgui Li, Xu-Jian Luo, et al.. (2014). Synthesis, crystal structure and DNA interaction studies of a 2D cadmium(II) coordination polymer constructed from 2-(2-pyridyl)benzimidazole. Supramolecular chemistry. 27(4). 281–286. 6 indexed citations
11.
Luo, Xu-Jian, Qi‐Pin Qin, Yulan Li, Yan‐Cheng Liu, & Liang Hong. (2014). Synthesis, antitumor activity and G-quadruplex DNA/ct-DNA binding property of a cationic platinum(II) complex of 2-(4-nitro)-imidazo-[5,6- f ][1,10]-phenanthroline. 2 indexed citations
12.
Luo, Xu-Jian, Qi‐Pin Qin, Yulan Li, et al.. (2014). Three platinum(II) complexes of 2-(methoxy-phenyl)-imidazo-[4,5-f]-[1,10] phenanthroline: cell apoptosis induction by sub-G1 phase cell cycle arrest and G-quadruplex binding properties. Inorganic Chemistry Communications. 46. 176–179. 15 indexed citations
13.
Luo, Xu-Jian, Chuan‐Hui Zhang, Jie Zhou, & Yan‐Cheng Liu. (2013). Bis[4-chloro-2-(quinolin-8-yliminomethyl)phenolato-κ3N,N′,O]cobalt(III) trichloridomethanolcobaltate(II). Acta Crystallographica Section E Structure Reports Online. 69(5). m278–m279. 3 indexed citations
14.
Luo, Xu-Jian, Qi‐Pin Qin, Ke-Bin Huang, Yan‐Cheng Liu, & Hong Liang. (2013). Spectroscopic Studies on the Interaction of Hemin with Human Telomeric G-Quadruplex DNA. Asian Journal of Chemistry. 25(11). 6396–6400. 3 indexed citations
16.
Li, Yulan, Qi‐Pin Qin, Yan‐Cheng Liu, et al.. (2013). Study on potential antitumor mechanism of quinoline-based silver(I) complexes: Synthesis, structural characterization, cytotoxicity, cell cycle and caspase-initiated apoptosis. Inorganic Chemistry Communications. 40. 73–77. 19 indexed citations
17.
Tan, Ming‐Xiong, et al.. (2012). Fluorescence Spectroscopy Study on the Interaction between Evodiamine and Bovine Serum Albumin. SHILAP Revista de lepidopterología. 2013(1). 34 indexed citations
18.
19.
Tan, Ming‐Xiong, et al.. (2011). Antioxidant Activities of Plumbagin and Its Cu (II) Complex. SHILAP Revista de lepidopterología. 2011. 1–5. 27 indexed citations
20.
Wang, Yanfei, Hongli Zou, Xu-Jian Luo, Zhen‐Feng Chen, & Hong Liang. (2010). trans-Bis[4-amino-N-(pyrimidin-2-yl)benzenesulfonamidato]dipyridinecobalt(II) hemihydrate. Acta Crystallographica Section E Structure Reports Online. 66(5). m548–m548. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026